Expression of Epstein-Barr virus in Hodgkin lymphoma in a population of United Arab Emirates nationals

Leukemia and Lymphoma

Volumn 49, Issue 9, 2008, Pages 1769-1777

  Al Salam, Suhail ^a   John, Anne ^b   Daoud, Sayel ^b   Chong, Siew Ming ^a   Castella, Antonio ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b TAWAM HOSPITAL   (United Arab Emirates)

Author keywords

Epstein Barr Virus; Hodgkin lymphoma; UAE

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FEMALE; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENCE; LYMPHOCYTE DEPLETION HODGKIN LYMPHOMA; LYMPHOCYTE-RICH CLASSICAL HODGKIN LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MIXED CELLULARITY HODGKIN LYMPHOMA; NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA; NODULAR SCLEROSIS HODGKIN LYMPHOMA; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; STAINING; TISSUE SECTION; UNITED ARAB EMIRATES; VIRUS EXPRESSION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CHILD; CHILD, PRESCHOOL; FEMALE; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; IMMUNOPHENOTYPING; INCIDENCE; MALE; MIDDLE AGED; UNITED ARAB EMIRATES;

EID: 52349091340     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190802270894     Document Type: Article

References (46)

1. Marafioti, T., Hummel, M., Foss, H. D., Laumen, H., Korbjuhn, P. Anagnostopoulos, I. et al. (2000) Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood, 95, pp. 1443-1450.
2. Higgins, R. A., Blankenship, J. E. and Kinney, M. C. (2008) Application of immunohistochemistry in the diagnosis of non-Hodgkin and Hodgkin lymphoma. Arch Pathol Lab Med, 132, pp. 441-461.
3. Castella, A., Joshi, S., Raaschou, T. and Mason, N. (2001) Pattern of malignant lymphoma in the United Arab Emirates-a histopathologic and immunologic study in 208 native patients. Acta Oncol, 40, pp. 660-664.
4. Bamanikar, S., Thunold, S., Devi, K RL and Bamanikar, A. (1995) The pattern of malignant lymphoma in Oman. J Tropical Med Hyg, 98, pp. 351-354.
5. Glaser, S. L., Lin, R. J., Stewart, S. L., Ambinder, R. F., Jarrett, R. F. Brousset, P. et al. (1997) Epstein-Barr virus-associated Hodgkin's disease: Epidemiologic characteristics in international data. Int J Cancer, 70, pp. 375-382.
6. Harris, N. L. (1998) The many faces of Hodgkin's disease around the world: What have we learned from its pathology?. Ann Oncol, 9, pp. S45-S56.
7. Kawa, K. (2000) Epstein-Barr virus-associated diseases in humans. Int J Hematol, 71, pp. 108-117.
8. Niedobitek, G., Meru, N. and Delecluse, H. (2001) Epstein-Barr virus infection and human malignancies. Int J Exp Pathol, 82, pp. 149-170.
9. Okano, M. (1998) Epstein-Barr virus infection and its role in the expanding spectrum of human diseases. Acta Paediatr, 87, pp. 11-18.
10. Khan, G., Norton, A. J. and Slavin, G. (1993) Epstein-Barr virus in Hodgkin disease. Relation to age and subtype. Cancer, 71, pp. 3124-3129.
11. Kusuda, M., Toriyama, K., Kamidigo, N. O. and Itakura, H. (1998) A comparison of epidemiologic, histologic and virologic studies on Hodgkin's disease in Western Kenya and Nagasaki, Japan. Am J Trop Med Hyg, 59, pp. 801-807.
12. Leoncini, L., Spina, D., Nyong'o, A., Abinya, O., Minacci, C. Disanto, A. et al. (1996) Neoplastic cells of Hodgkin's disease show differences in EBV expression between Kenya and Italy. Int J Cancer, 65, pp. 781-784.
13. Liu, S. M., Chow, K. C., Chiu, C. F. and Tzeng, C. H. (1998) Expression of Epstein-Barr virus in patients with Hodgkin's disease in Taiwan. Cancer, 83, pp. 367-371.
14. Makar, R. R., Saji, T. and Junaid, T. A. (2003) Epstein-Barr virus expression in Hodgkin's Lymphoma in Kuwait. Pathol Oncol Res, 9, pp. 159-165.
15. Mourad, W., Alsohaibani, M. O., Saddik, M. and Bazerbashi, S. (1998) Epstein-Barr virus expression in Hodgkin's disease: Correlation with histologic subtypes and T and B lymphocyte distribution. Ann Saudi Med, 18, pp. 296-300.
16. Oudejans, J. J., Jiwa, N. M. and Meijer, C. J. (1997) Epstein-Barr virus in Hodgkin's disease: More than just an innocent bystander. J Pathol, 181, pp. 353-356.
17. Peh, S. C., Looi, L. M. and Pallesen, G. (1997) Epstein-Barr virus (EBV) and Hodgkin's disease in a multi-ethnic population in Malaysia. Histopathology, 30, pp. 227-233.
18. Kandil, A., Bazarbashi, S. and Mourad, W. (2001) The correlation of Epstein-Barr virus expression and lymphocyte subsets with the clinical presentation of nodular sclerosing Hodgkin disease. Cancer, 91, pp. 1957-1963.
19. Mughal, T. I., Robinson, W. A. and Padmos, M. A. (1985) Adult Hodgkin's disease in Saudi Arabia. Eur J Surg Oncol, 11, pp. 41-45.
20. Knight, J. S., Sharma, N. and Robertson, E. S. (2005) Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase. Proc Natl Acad Sci U S A, 102:20, pp. 18562-18566.
21. Jarrett, R. F., Stark, G. L., White, J., Angus, B., Alexander, F. E. Krajewski, A. S. et al. (2005) Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: A population-based study. Blood, 106, pp. 2444-2451.
22. Savoldo, B., Rooney, C. M., Di Stasi, A, Abken, H., Hombach, A. Foster, A. E. et al. (2007) Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease. Blood, 110, pp. 2620-2630.
23. Lu, X. L., Liang, Z. H., Zhang, C. E., Lu, S. J., Weng, X. F. and Wu, X. W. (2006) Induction of the Epstein-Barr virus latent membrane protein 2 antigen-specific cytotoxic T lymphocytes using human leukocyte antigen tetramer-based artificial antigen-presenting cells. Acta Biochim Biophys Sin (Shanghai), 38, pp. 157-163.
24. Park, J. H. and Faller, D. V. (2002) Epstein-Barr virus latent membrane protein-1 induction by histone deacetylase inhibitors mediates induction of intercellular adhesion molecule-1 expression and homotypic aggregation. Virology, 303, pp. 345-363.
25. Rowe, M., Khanna, R., Jacob, C. A., Argaet, V., Kelly, A. Powis, S. et al. (1995) Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate upregulation of peptide transporters and HLA class I antigen expression. Eur J Immunol, 25, pp. 1374-1384.
26. Murray, P. G., Billingham, L. J., Hassan, H. T., Flavell, J. R., Nelson, P. N. Scott, K. et al. (1999) Effect of Epstein-Barr virus infection on response to chemotherapy and survival in Hodgkin's disease. Blood, 94, pp. 442-447.
27. Morente, M. M., Piris, M. A., Abraira, V., Acevedo, A., Aguilera, B. Bellas, C. et al. (1997) Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression. High Ki67 proliferation index and absence of Epstein-Barr virus-latent membrane protein 1 expression. Blood, 90, p. 2429.
28. Mei, Y. P., Zhou, J. M., Wang, Y., Huang, H., Deng, R. Feng, G. K. et al. (2007) Silencing of LMP1 induces cell cycle arrest and enhances chemosensitivity through inhibition of AKT signaling pathway in EBV-positive nasopharyngeal carcinoma cells. Cell Cycle, 6, pp. 1379-1385.
29. Cancer incidence report 1998-2002 (2002) UAE: UAE national cancer registry, Department for disease control. Ministry of Health
30. Almasri, N. M. and Khalidi, H. S. (2004) Epstein-Barr virus expression in Hodgkin's disease in Jordan. Saudi Med J, 25, pp. 770-775.
31. Adamson, P., Bray, F., Costantini, A. S., Tao, M. H., Weiderpass, E. and Roman, E. (2007) Time trends in the registration of Hodgkin and non-Hodgkin lymphomas in Europe. Eur J Cancer, 43, pp. 391-401.
32. Morton, L. M., Wang, S. S., Devesa, S. S., Hartge, P., Weisenburger, D. D. and Linet, M. S. (2006) Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood, 107, pp. 265-276.
33. Chai, S. P., Peh, S. C., Kim, L. H., Lim, M. Y. and Gudum, H. R. (1999) The pattern of lymphoma in east Malaysian patients as experienced in the University Hospital, Kuala Lumpur. Malays J Pathol, 21, pp. 45-50.
34. Huh, J., Park, C., Juhng, S., Kim, C. E., Poppema, S. and Kim, C. (1996) A pathologic study of Hodgkin's disease in Korea and its association with Epstein-Barr virus infection. Cancer, 77, pp. 949-955.
35. Flavell, K. J. and Murray, P. G. (2000) Hodgkin's disease and the Epstein-Barr virus. J Clin Pathol: Mol Pathol, 53, pp. 262-269.
36. Mueller, N. E. and Grufferman, S. (1999) The epidemiology of Hodgkin's disease. Hodgkin's Diseases, pp. 61-77. Lippincott Williams & Wilkins, Philadelphia, USA
37. MacMahon, B. (1966) Epidemiology of Hodgkin's disease. Cancer Res, 26, pp. 1189-1200.
38. Azzam, S. A. (1966) High incidence of Hodgkin's disease in children in Lebanon. Cancer Res, 26, pp. 1202-1203.
39. Gad-El-Mawla, N., El-Deeb, B. B., Abu-Gabal, A., Abdel-Hadi, S., Hamza, M. R. Zikri, Z. K. et al. (1983) Pediatric Hodgkin's disease in Egypt. Cancer, 52, pp. 1129-1131.
40. Motawy, M. S. and Omar, Y. T. (1986) Hodgkin's disease in children in Kuwait. Cancer, 57, pp. 2255-2259.
41. Al-Idrissi, H Y and Ibrahim, E. M. (1991) Hodgkin's disease in adults in Saudi Arabia. Clinical features, prognostic factors and an analysis of therapy. Outcome of combination chemotherapy only for both localized and advanced disease. Int J Cancer, 47, pp. 822-826.
42. Chang, K. L., Albujar, P. F., Chen, Y. Y., Johnson, R. M. and Weiss, L. M. (1993) High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin's disease occurring in Peru. Blood, 81, pp. 496-501.
43. Enblad, G., Sandvej, K., Sundstrom, C., Pallesen, G. and Glimelius, B. (1999) Epstein-Barr virus distribution in Hodgkin's disease in an unselected Swedish population. Acta Oncologica, 38, pp. 425-429.
44. Chapman, A. L., Rickinson, A. B., Thomas, W. A., Jarrett, R. F., Crocker, J. and Lee, S. P. (2001) Epstein-Barr virus-specific cytotoxic T lymphocyte responses in the blood and tumor site of Hodgkin's disease patients: Implications for a T-cell-based therapy. Cancer Res, 61, pp. 6219-6226.
45. Ambinder, R. F., Browning, P. J., Lorenzana, I., Leventhal, B. G., Cosenza, H. Mann, R. B. et al. (1993) Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States. Blood, 81, pp. 462-467.
46. Weinreb, M., Day, P. J., Murray, P. G., Raafat, F., Crocker, J. Parkes, S. E. et al. (1992) Epstein-Barr virus (EBV) and Hodgkin's disease in children: Incidence of EBV latent membrane protein in malignant cells. J Pathol, 168, pp. 365-369.